Associate Chief Pharmacist - Technical Services

We are looking for an inspirational senior pharmacy leader to join our Pharmacy and Medicines Optimisation Directorate as Associate Chief Pharmacist, Technical Services. You will lead a large and complex portfolio of aseptic preparation services spanning chemotherapy, advanced therapies, clinical trials and other aseptically prepared medicines, with responsibility for quality management, regulatory assurance, operational delivery, workforce, finance and future service development. You will have the opportunity to shape the running of two new aseptic units due to open in 2027 providing adult and paediatric chemotherapy and advanced therapies ensuring services meet current and future patient needs., Provide strategic, professional and operational leadership for the Trust's Aseptic Pharmacy Services. Ensure services are delivered to the required standards of patient safety, quality, governance and regulatory compliance, including Good Manufacturing Practice (GMP). Lead the development and transformation of aseptic services, supporting sustainable capacity and future service requirements. Provide senior leadership for workforce planning, development and performance, building resilient and effective technical services. Hold responsibility for the operational and financial performance of the services within the portfolio. Contribute as a senior member of the Pharmacy and Medicines Optimisation Directorate Management Team, supporting the wider strategic objectives of the pharmacy service and Trust. Provide expert professional advice and leadership on aseptic preparation and technical pharmacy matters, representing the service at senior level.

We have the one of the largest and most complex portfolios of aseptic preparation facilities in the region. There is a chemotherapy preparation unit and the advanced therapies containment suite within the Cancer Centre at Guy's; the CIVAS preparation unit at Guy's; a modular CIVAS preparation unit at St. Thomas' and a new chemotherapy and advanced therapies unit at St. Thomas' which will open in 2027. The Trusts' requirement for aseptically prepared ready-to-administer doses is growing and there are plans in place to further increase capacity through development of an off-site licensed aseptic unit in future.